Skip to main content
. 2016 Jan 18;6:19341. doi: 10.1038/srep19341

Figure 7. Schematic illustration of potential therapeutic applications of HDACi mediated human NIS modulation in breast cancer.

Figure 7

Upregulation of NIS expression during malignant transformation of breast tissue implicated therapeutic application of radioiodine in breast cancer management. To achieve enhanced therapeutic effect, stimulation of functional NIS expression by epigenetic modifiers such as HDACi is a promising strategy.